F. Zwaan

635 total citations
11 papers, 490 citations indexed

About

F. Zwaan is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, F. Zwaan has authored 11 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in F. Zwaan's work include Breast Cancer Treatment Studies (3 papers), Neutropenia and Cancer Infections (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). F. Zwaan is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), Neutropenia and Cancer Infections (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). F. Zwaan collaborates with scholars based in Saudi Arabia, United Arab Emirates and Netherlands. F. Zwaan's co-authors include D. W. van Bekkum, Raymond G. Hoffmann, Robert Peter Gale, Mortimer M. Bortin, Karel A. Dicke, John H. Kersey, Alberto M. Marmont, M.A. Raja, H. E. M. Kay and J. C. Biggs and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Annals of Oncology.

In The Last Decade

F. Zwaan

10 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Zwaan Saudi Arabia 9 269 182 143 82 69 11 490
ML Graham United States 9 188 0.7× 106 0.6× 115 0.8× 161 2.0× 37 0.5× 12 487
Ted Gooley United States 9 419 1.6× 123 0.7× 111 0.8× 66 0.8× 16 0.2× 15 614
Karin Landfried Germany 11 357 1.3× 114 0.6× 231 1.6× 99 1.2× 16 0.2× 14 609
P Hentschke Sweden 15 604 2.2× 255 1.4× 271 1.9× 65 0.8× 15 0.2× 25 791
Suzanne Tavitian France 14 463 1.7× 130 0.7× 118 0.8× 62 0.8× 57 0.8× 59 857
C. H. Tzeng Taiwan 13 180 0.7× 133 0.7× 35 0.2× 157 1.9× 20 0.3× 34 491
Theodora Foukaneli United Kingdom 8 474 1.8× 124 0.7× 142 1.0× 40 0.5× 23 0.3× 12 634
Michael Keng United States 11 148 0.6× 182 1.0× 67 0.5× 84 1.0× 16 0.2× 52 453
Alex Ganetsky United States 13 154 0.6× 177 1.0× 78 0.5× 109 1.3× 18 0.3× 35 504
S M Devine United States 9 289 1.1× 119 0.7× 31 0.2× 99 1.2× 29 0.4× 12 517

Countries citing papers authored by F. Zwaan

Since Specialization
Citations

This map shows the geographic impact of F. Zwaan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Zwaan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Zwaan more than expected).

Fields of papers citing papers by F. Zwaan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Zwaan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Zwaan. The network helps show where F. Zwaan may publish in the future.

Co-authorship network of co-authors of F. Zwaan

This figure shows the co-authorship network connecting the top 25 collaborators of F. Zwaan. A scholar is included among the top collaborators of F. Zwaan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Zwaan. F. Zwaan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kristensen, Jörgen, F. Zwaan, Antonio Castella, et al.. (2004). [Life-threatening gastrointestinal bleeding related to the treatment of strongyloidiasis hyperinfection in an immunocompromised patient].. PubMed. 145(4). 181–5. 1 indexed citations
2.
3.
Ellis, Michael, et al.. (2001). Severe Hepatic Injury Associated with Lipid Formulations of Amphotericin B. Clinical Infectious Diseases. 32(5). e87–e89. 12 indexed citations
4.
Raja, M.A., et al.. (1998). The lack of age as a significant prognostic factor in nonmetastatic breast cancer. European Journal of Surgical Oncology. 24(1). 23–27. 26 indexed citations
5.
Ezzat, Adnan, et al.. (1997). A phase II trial of circadian-timed paclitaxel and cisplatin therapy in metastatic breast cancer. Annals of Oncology. 8(7). 663–667. 23 indexed citations
6.
Ezzat, Adnan, M.A. Raja, A.Y. Rostom, et al.. (1997). An Overview of Breast Cancer. Annals of Saudi Medicine. 17(1). 10–15. 35 indexed citations
7.
Ellis, Michael, et al.. (1996). High Incidence of Line-Related Infection and Mechanical Failure of an Antiseptic Impregnated Central Venous Catheter in Highly Immunocompromised Patients. Scandinavian Journal of Infectious Diseases. 28(1). 91–93. 16 indexed citations
8.
Ezzat, Adnan, M.A. Raja, John Berry, et al.. (1996). Impact of pregnancy on non-metastatic breast cancer: A case control study. Clinical Oncology. 8(6). 367–370. 43 indexed citations
9.
Nadeem, Fahd, et al.. (1994). Does Aprotinin Cause Renal Dysfunction in Cardiac Surgery PATIENTS?. Anesthesiology. 81(SUPPLEMENT). A91–A91. 2 indexed citations
10.
Planque, Mariet M. de, Anneke Brand, Hanneke C. Kluin‐Nelemans, et al.. (1989). Haematopoietic and immunologic abnormalities in severe aplastic anaemia patients treated with anti‐thymocyte globulin. British Journal of Haematology. 71(3). 421–430. 17 indexed citations
11.
Gale, Robert Peter, Mortimer M. Bortin, D. W. van Bekkum, et al.. (1987). Risk factors for acute graft‐versus‐host disease. British Journal of Haematology. 67(4). 397–406. 272 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026